Established in January 2003, the PharmacoGenomics Research Center found its home in June of the same year, on the 6th floor of the extension building of the Inje College of Medicine located in Geagum, Busan, South Korea. Professor Jae-Gook Shin currently heads the Center as its first chief and along with the faculty of the Center, many other professors support and are supported by the Center: Professor Seong-Su Yea, Department of Biochemistry; Professor Byeong-Du Lee, Department of Internal Medicine; Professor Jin-Ho Chun, Department of Preventive Medicine; Professor Joo-Cheol Shim, Department of Neuropsychiatry; and Professor Chun-Gyu Kim, Department of Pharmaceutical Science. The Center is the first institute for pharmacogenomic studies in Korea and leads domestic research on this subject.
Designated as a state-supporting research institute, the Center is equipped with cutting edge technology needed to conduct pharmacogenomics research. The Research Center leads Korea in the science of drug metabolizing enzymes, drug transporters, Carcinostatis Substances, etc, and to develop tailored pharmacotherapy based on clinical trials. Particularly, the Center is recognized to have a considerable technology level in the areas of drug metabolizing enzymes and drug transporters. The Center’s major research areas are about pharmacogenomics and tailored pharmacotherapy, drug metabolism & interactions, drug transferring substances, clinical pharmacokinetics/pharmacodynamics, Therapeutic Drug Monitoring (TDM) and population pharmacokinetics, clinical toxicology, etc. Based on its clinical pharmacological knowledge and technology, the Research Center performs clinical demonstrations to develop new drugs and offers TDM and appropriate pharmacotherapeutic adjustment services with the Clinical Trial Center, at Busan Paik Hospital.
Our research centers are looking for additional talented Msc-level researchers to meet the demand of challenging projects.
Center for Personalized Precision Medicine of Tuberculosis, Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea
– The candidates must demonstrate exemplary skills in general molecular biology techniques, including cell maintenance, in vitro phenotypic testing, and nucleic acid and protein-related experiments (RT-PCR, ELISA, FACS, and WB).
– Highly collaborative and proactive.
In addition, candidates with one or more of the below qualifications are preferred.
– Experience in elucidating molecular mechanisms related to the toxic effects of drugs and chemicals (in vitro/in vivo).
– Experience working with siRNA, shRNA, or CRISPR/Cas9-based gene KD/KO (in vitro).
– Experience with in vivo models.
– Experience with multiplex techniques, such as SNaPshot (genotyping) and Luminex (immunoassay).
– Be able to communicate in Korean.
– Involve in the experimental planning, design, and execution of various projects of the center.
– Develop the protocols and SOPs.
– Maintain lab notes and other crucial documents.
– Report (weekly/biweekly) to the direct supervisor.
– Friendly and supportive environment.
– New technical skill training.
– Career coaching and development.
– Co/first-author of the scientific publications.
– Top tier salary for entry-level/fresh MSc graduates (in Korea) and other benefits according to Korean laws/university policies.
Should you be interested in the position, please send a CV and cover letter to Prof. Nguyen Phuoc Long (bsngphuoclong<at>gmail<dot>com). Only a short list of potential candidates will be notified for an interview.
To know more about Prof. Long, please visit his website: https://pharmomicslab.site/